COVID-19

Study explores parents’ reluctance to flu, COVID vaccines for children

Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children.

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.

Major grant renewal to provide five more years of support for VICTR

Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.

Black patients with cancer face worse COVID outcomes: study

Vanderbilt researchers have found that Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.

Crowe receives national award for COVID antibody research

Vanderbilt’s James Crowe Jr., MD, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19.

Uncharted days of the COVID-19 pandemic strengthen the Vanderbilt Vaccine Research Program team.

“There’s something about having a band of brothers, where you’re all focused on the same thing, and your noses are all pointed in the same direction.”

Jane Storie is one of many patients who are experiencing cognitive impairment after recovering from COVID-19. The long-term complication is also impacting her family — husband, James, daughter, Emily, and son, Andrew.

Team helps patients battle post-COVID cognitive issues

Jane Stories is one of many COVID-19 patients still plagued by debilitating symptoms that include achy muscles, anxiety, depression, panic attacks and cognitive impairment.

1 5 6 7 8 9 40